The company’s first quarter ended Aug. 31. During the first quarter last year, Biomet lost $31.5 million.
Sports, extremities and trauma devices brought much of this year’s profit; the segment earned $149.5 million this year, up 17.4 percent from 2012. Knees were also profitable, bringing in $225.1 million or 3.5 percent more than last year.
More Articles on Devices:
X-Stop Spine Surgery: Outcomes Analysis
19 Spine Devices Get FDA 510(k) Clearance in September
Spine Wave Implements iTraycer for Implants
